» Articles » PMID: 20622013

Curcumin Decreases Amyloid-beta Peptide Levels by Attenuating the Maturation of Amyloid-beta Precursor Protein

Overview
Journal J Biol Chem
Specialty Biochemistry
Date 2010 Jul 13
PMID 20622013
Citations 63
Authors
Affiliations
Soon will be listed here.
Abstract

Alzheimer disease (AD) is a devastating neurodegenerative disease with no cure. The pathogenesis of AD is believed to be driven primarily by amyloid-beta (Abeta), the principal component of senile plaques. Abeta is an approximately 4-kDa peptide generated via cleavage of the amyloid-beta precursor protein (APP). Curcumin is a compound in the widely used culinary spice, turmeric, which possesses potent and broad biological activities, including anti-inflammatory and antioxidant activities, chemopreventative effects, and effects on protein trafficking. Recent in vivo studies indicate that curcumin is able to reduce Abeta-related pathology in transgenic AD mouse models via unknown molecular mechanisms. Here, we investigated the effects of curcumin on Abeta levels and APP processing in various cell lines and mouse primary cortical neurons. We show for the first time that curcumin potently lowers Abeta levels by attenuating the maturation of APP in the secretory pathway. These data provide a mechanism of action for the ability of curcumin to attenuate amyloid-beta pathology.

Citing Articles

Evaluation of the Anti-Amyloid and Anti-Inflammatory Properties of a Novel Vanadium(IV)-Curcumin Complex in Lipopolysaccharides-Stimulated Primary Rat Neuron-Microglia Mixed Cultures.

Katsipis G, Lavrentiadou S, Geromichalos G, Tsantarliotou M, Halevas E, Litsardakis G Int J Mol Sci. 2025; 26(1.

PMID: 39796150 PMC: 11720140. DOI: 10.3390/ijms26010282.


Role of curcumin on beta-amyloid protein, tau protein, and biochemical and oxidative changes in streptozotocin-induced diabetic rats.

Ermis M, Ciftci G Naunyn Schmiedebergs Arch Pharmacol. 2024; 397(12):9833-9844.

PMID: 38922352 PMC: 11582150. DOI: 10.1007/s00210-024-03231-3.


Research Progress on Natural Plant Molecules in Regulating the Blood-Brain Barrier in Alzheimer's Disease.

Wu W, Huang J, Han P, Zhang J, Wang Y, Jin F Molecules. 2023; 28(22).

PMID: 38005352 PMC: 10674591. DOI: 10.3390/molecules28227631.


Research Mechanism and Progress of the Natural Compound Curcumin in Treating Alzheimer´s Disease.

Li L, Wang F, Jia X, Yao L, Liu Y Mini Rev Med Chem. 2023; 24(17):1590-1601.

PMID: 37929738 DOI: 10.2174/0113895575263783231009051957.


A Photolabile Curcumin-Diazirine Analogue Enables Phototherapy with Physically and Molecularly Produced Light for Alzheimer's Disease Treatment.

Kuang S, Zhu B, Zhang J, Yang F, Wu B, Ding W Angew Chem Int Ed Engl. 2023; 62(45):e202312519.

PMID: 37721455 PMC: 10615883. DOI: 10.1002/anie.202312519.


References
1.
Ganguli M, Chandra V, Kamboh M, Johnston J, Dodge H, Thelma B . Apolipoprotein E polymorphism and Alzheimer disease: The Indo-US Cross-National Dementia Study. Arch Neurol. 2000; 57(6):824-30. DOI: 10.1001/archneur.57.6.824. View

2.
Egan M, Pearson M, Weiner S, Rajendran V, Rubin D, Glockner-Pagel J . Curcumin, a major constituent of turmeric, corrects cystic fibrosis defects. Science. 2004; 304(5670):600-2. DOI: 10.1126/science.1093941. View

3.
Kelloff G, Boone C, Crowell J, Nayfield S, Hawk E, Steele V . Perspectives and progress in development of breast cancer chemopreventive drugs. Prog Clin Biol Res. 1997; 396:159-83. View

4.
Gandy S . The role of cerebral amyloid beta accumulation in common forms of Alzheimer disease. J Clin Invest. 2005; 115(5):1121-9. PMC: 1087184. DOI: 10.1172/JCI25100. View

5.
Tanzi R, Bertram L . Twenty years of the Alzheimer's disease amyloid hypothesis: a genetic perspective. Cell. 2005; 120(4):545-55. DOI: 10.1016/j.cell.2005.02.008. View